If the market was never going to use the product that way, why validate it that way?

Medtech R&D teams obsess over performance qualification, installation qualification, and operational qualification.

Fewer ask the more uncomfortable question first:
Did we qualify the market?

Market Qualification, or MQ, means pressure-testing whether clinicians will actually use, value, and adopt a product the way it was designed. Not in theory. Not in a controlled setting. In the real workflows the product is entering.

That step is often skipped.

The Risk No One Talks About

McKinsey & Company reports that ~70% of transformation and innovation efforts fall short of their intended targets.

Not because the product doesn’t work.
Because the product doesn’t land.

R&D teams validate performance. They validate safety. They validate reliability.

But many never validate whether the market will behave the way the product assumes it will.

If the workflow was never going to support the product, if the training burden was underestimated, or if the perceived value does not outweigh the operational cost, failure was already built in long before launch.

MQ Changes the Odds

Research from the Product Development and Management Association shows that products developed with strong user input are up to 2x more likely to succeed.

That is the difference MQ creates.

Not more validation.
Better validation.

Instead of asking “does it work?”
MQ forces teams to ask:

• Will clinicians actually use it this way?
• Does it fit into real workflows without friction?
• Does the operational burden justify the value?

Those answers do not come from internal alignment. They come from the market itself.

Where Most Teams Go Wrong

Many teams rely on:

• Internal assumptions
• Friendly users
• Secondhand feedback from commercial teams

Those inputs can directionally help. They do not replicate real-world behavior.

This is where the gap shows up later:

• Adoption slower than expected
• Field feedback inconsistent
• Resistance from users R&D never anticipated

The product performs.
The workflow breaks.

MQ Is Not Research. It Is Risk Control.

Voice of customer work reveals what the market actually values, resists, or misunderstands.
Usability studies expose interaction and workflow friction.
Human factors research shows how real-world use conditions affect product experience and acceptance.

TCX positions Clinical Market Insights around engaging customers from ideation through development so these insights show up early, when they are still actionable.

Because once the product is built, those insights become expensive.

The Reality

PQ, IQ, and OQ validate the product.

MQ validates the environment the product is entering.

If your team is hearing that adoption is stalling, the question is not whether the product was validated.

It is whether the market ever was.

And in many cases, that is the step that should have come first.

Let’s Talk

Visit our Market Qualification campaign page to see how TCX helps medtech R&D teams use voice of customer, usability, and human factors insight to uncover adoption barriers before the market pushes back.